These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 32331438)

  • 1. HIV-1 Sub-Subtype A6: Settings for Normalised Identification and Molecular Epidemiology in the Southern Federal District, Russia.
    Schlösser M; Kartashev VV; Mikkola VH; Shemshura A; Saukhat S; Kolpakov D; Suladze A; Tverdokhlebova T; Hutt K; Heger E; Knops E; Böhm M; Di Cristanziano V; Kaiser R; Sönnerborg A; Zazzi M; Bobkova M; Sierra S
    Viruses; 2020 Apr; 12(4):. PubMed ID: 32331438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic Features of HIV-1 Integrase Sub-Subtype A6 Predominant in Russia and Predicted Susceptibility to INSTIs.
    Kirichenko A; Lapovok I; Baryshev P; van de Vijver DAMC; van Kampen JJA; Boucher CAB; Paraskevis D; Kireev D
    Viruses; 2020 Jul; 12(8):. PubMed ID: 32752001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV Type 1 Integrase Natural Polymorphisms in Viral Variants Circulating in FSU Countries.
    Lapovok I; Laga V; Kazennova E; Bobkova M
    Curr HIV Res; 2017 Nov; 15(5):318-326. PubMed ID: 28814231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV-1 genetic diversity and drug resistance among treatment naïve patients from Southern Brazil: an association of HIV-1 subtypes with exposure categories.
    Gräf T; Passaes CP; Ferreira LG; Grisard EC; Morgado MG; Bello G; Pinto AR
    J Clin Virol; 2011 Jul; 51(3):186-91. PubMed ID: 21622023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV epidemiology in the Northwestern Federal District of Russia: dominance of HIV type 1 subtype A.
    Smolskaya T; Liitsola K; Zetterberg V; Golovanova E; Kevlova N; Konovalova N; Sevastianova K; Brummer-Korvenkontio H; Salminen M
    AIDS Res Hum Retroviruses; 2006 Nov; 22(11):1074-80. PubMed ID: 17147492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular Epidemiology of HIV-1 in Eastern Europe and Russia.
    van de Klundert MAA; Antonova A; Di Teodoro G; Ceña Diez R; Chkhartishvili N; Heger E; Kuznetsova A; Lebedev A; Narayanan A; Ozhmegova E; Pronin A; Shemshura A; Tumanov A; Pfeifer N; Kaiser R; Saladini F; Zazzi M; Incardona F; Bobkova M; Sönnerborg A
    Viruses; 2022 Sep; 14(10):. PubMed ID: 36298654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Investigation of HIV-1 primary drug resistance mutations in antiretroviral therapy-naive cases].
    Yalçınkaya T; Köse S
    Mikrobiyol Bul; 2014 Oct; 48(4):585-95. PubMed ID: 25492654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Molecular characterization of complex recombinant HIV-1 CRF06_cpx subtype detected in Turkey].
    Sayan M; Kaptan F; Ormen B; Türker N
    Mikrobiyol Bul; 2014 Jan; 48(1):160-7. PubMed ID: 24506727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surveillance of HIV-1 pol transmitted drug resistance in acutely and recently infected antiretroviral drug-naïve persons in rural western Kenya.
    Onywera H; Maman D; Inzaule S; Auma E; Were K; Fredrick H; Owiti P; Opollo V; Etard JF; Mukui I; Kim AA; Zeh C
    PLoS One; 2017; 12(2):e0171124. PubMed ID: 28178281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evolution of transmitted HIV-1 drug resistance and viral subtypes circulation in Italy from 2006 to 2016.
    Rossetti B; Di Giambenedetto S; Torti C; Postorino MC; Punzi G; Saladini F; Gennari W; Borghi V; Monno L; Pignataro AR; Polilli E; Colafigli M; Poggi A; Tini S; Zazzi M; De Luca A;
    HIV Med; 2018 Oct; 19(9):619-628. PubMed ID: 29932313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular diversity of HIV-1 and surveillance of transmitted drug resistance variants among treatment Naïve patients, 5 years after active introduction of HAART in Kuala Lumpur, Malaysia.
    Ong LY; Razak SN; Lee YM; Sri La Sri Ponnampalavanar S; Syed Omar SF; Azwa RI; Tee KK; Kamarulzaman A
    J Med Virol; 2014 Jan; 86(1):38-44. PubMed ID: 24127302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular Genetics and the Incidence of Transmitted Drug Resistance Among Pre-Treatment HIV-1 Infected Patients in the Eastern Cape, South Africa.
    Digban TO; Iweriebor BC; Obi LC; Nwodo U; Okoh AI
    Curr HIV Res; 2019; 17(5):335-342. PubMed ID: 31584370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Origin and evolution of HIV-1 subtype A6.
    Abidi SH; Aibekova L; Davlidova S; Amangeldiyeva A; Foley B; Ali S
    PLoS One; 2021; 16(12):e0260604. PubMed ID: 34898626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic analysis of HIV type 1 strains from newly infected untreated patients in cyprus: high genetic diversity and low prevalence of drug resistance.
    Kousiappa I; van de Vijver DA; Demetriades I; Kostrikis LG
    AIDS Res Hum Retroviruses; 2009 Jan; 25(1):23-35. PubMed ID: 19182918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Postmortem Molecular Epidemiology of HIV-1 Strains Isolated in Turkey].
    Ziyade N; Sayan M; Elgörmüş N; Büyük Y
    Mikrobiyol Bul; 2019 Oct; 53(4):374-387. PubMed ID: 31709935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular epidemiology and prevalence of drug resistance-associated mutations in newly diagnosed HIV-1 patients in Portugal.
    Palma AC; Araújo F; Duque V; Borges F; Paixão MT; Camacho R;
    Infect Genet Evol; 2007 Jun; 7(3):391-8. PubMed ID: 17360244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phylodynamic evolution of HIV-1 A6 sub-subtype epidemics in Poland.
    Serwin K; Scheibe K; Urbańska A; Aksak-Wąs B; Karasińska-Cieślak M; Ząbek P; Siwak E; Cielniak I; Jabłonowska E; Wójcik-Cichy K; Jakubowski P; Bociąga-Jasik M; Witor A; Szymczak A; Szetela B; Parczewski M
    J Med Virol; 2024 Feb; 96(2):e29482. PubMed ID: 38381668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV-1 Drug Resistance among Treatment-Naïve Patients in Russia: Analysis of the National Database, 2006-2022.
    Kirichenko A; Kireev D; Lapovok I; Shlykova A; Lopatukhin A; Pokrovskaya A; Bobkova M; Antonova A; Kuznetsova A; Ozhmegova E; Shtrek S; Sannikov A; Zaytseva N; Peksheva O; Piterskiy M; Semenov A; Turbina G; Filoniuk N; Shemshura A; Kulagin V; Kolpakov D; Suladze A; Kotova V; Balakhontseva L; Pokrovsky V; Akimkin V
    Viruses; 2023 Apr; 15(4):. PubMed ID: 37112971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transmitted drug resistance mutations and trends of HIV-1 subtypes in treatment-naïve patients: A single-centre experience.
    Mazzuti L; Melengu T; Falasca F; Calabretto M; Cella E; Ciccozzi M; Mezzaroma I; Iaiani G; Spaziante M; d'Ettorre G; Fimiani C; Vullo V; Antonelli G; Turriziani O
    J Glob Antimicrob Resist; 2020 Mar; 20():298-303. PubMed ID: 31518723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of HIV-1 diversity, primary drug resistance and transmission networks in Croatia.
    Oroz M; Begovac J; Planinić A; Rokić F; Lunar MM; Zorec TM; Beluzić R; Korać P; Vugrek O; Poljak M; Lepej SŽ
    Sci Rep; 2019 Nov; 9(1):17307. PubMed ID: 31754119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.